Skip to content

ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques.

A Retrospective Multicentric Clinical Study Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed in the Intraoperative Localization of Non-palpable Breast Lesions During Breast Conservative Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05942092
Acronym
SEED01
Enrollment
1400
Registered
2023-07-12
Start date
2023-04-26
Completion date
2028-09-30
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Non-palpable breast lesion

Brief summary

Nowadays, Breast Conservative Surgery (BCS) is the standard of care for patients affected by early breast lesions. Screening programmes led to an increase of impalpable breast lesion detection rates. These patients are often eligible for BCS and an accurate preoperative localization technique for the detection of the lesion is required in order to guarantee a safe surgical excision. The primary goal of BCS is to obtain a complete resection of the tumor with disease-free surgical margins. The presence of tumor on surgical margins on postoperative histological examination of the specimen increases the risk of local recurrence and it requires a surgical re-excision. For all these reasons different techniques for localization of occult breast lesions have been developed over time. Since '70s, the wire guided localization (WGL) technique has represented the gold standard technique; however, it has several limitations such as wire migration or fracture and patient's referred discomfort related to wire placement. Other techniques have been proposed such as the ROLL and magnetic seeds. The ROLL consists of the injection of a radioactive substance into the breast lesion and the localization during surgery is allowed by using a handheld gamma probe. Limitations of this technique are represented by the need of radioactive injection the day before surgery with subsequent longer hospitalizations and the possible spread of the radioactive substance into breast tissue leading to larger resections. The latest technological evolution is represented by magnetic seeds, small devices deployed into the lesion even up to more than 30 days before surgery and identified with a specific magnetic probe during surgery. Currently there are several studies of comparison between the WGL and the more modern techniques. All of these data claim the effectiveness of the new "wire-free" methodics ensuring a safe surgical resection with tumor-free margins and, in some cases, a better aesthetic result. Studies of comparison between the modern techniques are limited. There is no scientific evidence of the superiority of magnetic seeds compared to ROLL. The aim of this retrospective study is to compare ROLL with magnetic seed to assess their efficacy in the localization of non-palpable breast lesions.

Interventions

PROCEDUREBreast conserving surgery

Breast conserving surgery after lesion's localization with ROLL or magnetic seed

Sponsors

Istituti Clinici Scientifici Maugeri SpA
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Female patients between 18 and 85 years who underwent to breast conservative surgery for non-palpable occult breast lesions; * Intraoperative localization of breast lesion with ROLL or magnetic seed; * Preoperative diagnosis on histology or cytology of borderline lesion (B3 or C3) or malignant lesion (B4-B5 or C4-C5).

Exclusion criteria

* B2 or C2 at preoperative needle breast biopsy or fine needle breast aspiration. * Breast tumor localization with clip for neoadjuvant chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Free-surgical margins6 monthsNumber of surgical procedures in which surgical margins are tumor disease-free ("no ink on tumor" for invasive cancer and margin of 2 mm for in situ-carcinoma).

Secondary

MeasureTime frameDescription
Excess breast resection6 monthsExcess breast resection calculated by the "calculated resection ratio" (CRR=total resection volume/optimal resection volume)
Surgery time6 monthsSurgery duration
Hospitalization's days6 monthsNumber of hospitalization's days
Complications6 monthsComplications occurred after biopsy or surgery
Reintervention6 monthsReintervention rates
Follow up5 years after enrollment5-years follow-up outcomes

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026